Schillingmann, D.A.; Riese, S.B.; Vijayan, V.; Tischer-Zimmermann, S.; Schmetzer, H.; Maecker-Kolhoff, B.; Blasczyk, R.; Immenschuh, S.; Eiz-Vesper, B.
Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy. Int. J. Mol. Sci. 2019, 20, 482.
https://doi.org/10.3390/ijms20030482
AMA Style
Schillingmann DA, Riese SB, Vijayan V, Tischer-Zimmermann S, Schmetzer H, Maecker-Kolhoff B, Blasczyk R, Immenschuh S, Eiz-Vesper B.
Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy. International Journal of Molecular Sciences. 2019; 20(3):482.
https://doi.org/10.3390/ijms20030482
Chicago/Turabian Style
Schillingmann, Damaris A., Sebastian B. Riese, Vijith Vijayan, Sabine Tischer-Zimmermann, Helga Schmetzer, Britta Maecker-Kolhoff, Rainer Blasczyk, Stephan Immenschuh, and Britta Eiz-Vesper.
2019. "Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy" International Journal of Molecular Sciences 20, no. 3: 482.
https://doi.org/10.3390/ijms20030482
APA Style
Schillingmann, D. A., Riese, S. B., Vijayan, V., Tischer-Zimmermann, S., Schmetzer, H., Maecker-Kolhoff, B., Blasczyk, R., Immenschuh, S., & Eiz-Vesper, B.
(2019). Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy. International Journal of Molecular Sciences, 20(3), 482.
https://doi.org/10.3390/ijms20030482